.coe{ font: normal 24px Trebuchet MS,sans-serif; color: #cc0033; padding: 6px 0; }

Breaking Through the Latest Breakthroughs.

Immuno-oncology has taken center stage in innovation in cancer treatment in recent years. Immunotherapy is the latest breakthrough, becoming an effective tool in prolonging the lives of patients with many different kinds of cancer. But while immunotherapy is effective in some cancers, it is not a universal tool, nor is it without its drawbacks, including severe and unpredictable toxicities.

.coe{ font: normal 24px Trebuchet MS,sans-serif; color: #cc0033; padding: 6px 0; }

In-House Technology.

Housed within Rutgers Cancer Institute is a Good Manufacturing Practices (GMP) facility. Our GMP facility enables the production of vectors and cells for adoptive cell transfer in support of clinical trials.

.coe{ font: normal 24px Trebuchet MS,sans-serif; color: #cc0033; padding: 6px 0; }

Further Advancing the Latest Technology.

.coe{ font: normal 24px Trebuchet MS,sans-serif; color: #cc0033; padding: 6px 0; }

How does cancer “work?”

And why do some cancers respond to immunotherapies, while others do not? Rutgers Cancer Institute has performed groundbreaking research into answering these questions by studying the tumor microenvironment. Under the tutelage of Dr.

.divTable{ display: table; width: 100%; } .divTableRow { display: table-row; } .divTableHeading { background-color: #EEE; display: table-header-group; } .divTableCell, .divTableHead { display: table-cell; padding: 3px 10px; height: auto; width: 100%; } .divTableBody { display: table-row-group; } { box-sizing: border-box; } /* Create two equal columns that float next to each other */ .column { float: left; width: 33%; padding: 20px; } /* Clear floats after the columns */ .row:after { content: ""; display: table; clear: both; } /*

.video-table { margin: auto; } .row { display: flex; flex-direction: row; flex-wrap: wrap; width: 100%; } .column { display: flex; flex-direction: column; flex-basis: 100%; flex: 2; }

Why Commemorate 50 Years of the National Cancer Act?